In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate
-
Correspondence: Andrea Savarino asavarino@medscape.com
Retrovirology 2007, 4:21 doi:10.1186/1742-4690-4-21
Accesses
- Last 30 days: 155 accesses
- Last 365 days: 2144 accesses
- All time: 15824 accesses